Topics Covered: After attending this activity, participants should be able to:
Evaluate the results of recent studies on molecular profiling of breast cancer, and consider how the use of such tools could identify at-risk patients and be used to determine the best treatment options for your patients with breast cancer.
Assess the efficacy of neoadjuvant regimens recently tested in clinical trials for the treatment of breast cancer, and how these treatments may benefit patients with breast cancer.
Discuss novel techniques in radiation therapy designed to optimize therapeutic dosage while minimizing the toxic effects in patients with breast cancer.
State the appropriate uses and settings for supportive care agents in patients with breast cancer undergoing both chemotherapy and radiation therapy, in order to optimize patient quality of life.
Evaluate the results of recent clinical trials investigating novel agents and regimens for the treatment of patients with advanced or metastatic breast cancer.
Who Should Attend: Physicians, Nurses, and Advanced Practicioners
Registration Information: Please see website for more information.
Conference Fees: Please see website for further information
Feb 9, 2011 - The incidence of non-melanoma skin cancer in the United States appears to be increasing, as individuals have failed to incorporate sun protection behaviors despite proven scientific evidence that sun exposure is a preventable risk factor, according to data presented at the annual meeting of the American Academy of Dermatology, held from Feb. 4 to 8 in New Orleans.